Nr565 chapter 7 - Study guides, Class notes & Summaries

566 Final Exam Study Guide Week 5 Prevention of osteoporosis with hormone replacement therapy (p. 433) Hormone therapy (HT) reduces postmenopausal bone loss & thereby decreases the risk for o steoporosis & related fractures. Unfortunately, when HT is stopped, bone mass rapidly decreases by approximately 12%. Hence to maintain bone health, HT must continue lifelong. As a result, the risk for harm is increased. Accordingly, alternative treatments are preferred. Effective alternatives to HT include...

NR565 Week 6 Study Outline 2021/2022 Many questions are written to assess your clinical application of the material from the textbook, in real-world scenarios. Chapter 24: Drugs used in treating infectious diseases (p. 760-796) Antimycobacterials-isoniazid (INH), rifamycin (RIF), pyrazinamide (PZA), ethambutol (EMB) Spectrum of coverage for various organisms- treats TB Pharmacodynamics- INH-interferes with lipid and nucleic acid biosynthesis. RIFInhibits RNA synthesis. Diffuses in...

NR 565 - WEEK 7&8 FINAL EXAM STUDY GUIDE. / NR 565 - WEEK 7&8 FINAL EXAM STUDY GUIDE. NR565 Week 7 & 8 Final Exam Study Outline Chapter 34: GERD and PUD (1021-1028) Ch. 20: Drugs affecting the GI system (497-533) ANTACIDS Antacids neutralize acids in the GI tract. Different combinations have differing acid neutralizing capacities. Sodium bicarbonate and calcium carbonate have the highest absolute neutrophil count (ANC)  Pharmacodynamics o Antacids neutralize gastric acid in the GI t...

NR565 Week 2 Study Guide (Page 1) Chapter 1: The Role of the Nurse Practitioner as Prescriber Roles and Responsibilities of APRN Prescribers APRN prescriber is responsible for the final decision on which drug to use and how to use it. Degree of autonomy in this role and the breadth of drugs that can be prescribed vary from state to state based on the nurse practice act of that state. Nurse practitioner prescriptive authority is regulated by the State Board of Nursing for each state. • A...

NR565 Week 2 Study Guide (Page 1) Chapter 1: The Role of the Nurse Practitioner as Prescriber Roles and Responsibilities of APRN Prescribers APRN prescriber is responsible for the final decision on which drug to use and how to use it. Degree of autonomy in this role and the breadth of drugs that can be prescribed vary from state to state based on the nurse practice act of that state. Nurse practitioner prescriptive authority is regulated by the State Board of Nursing for each state. • A...

NR565 / NR 565 Week 1 Study Outline Chapter 2, 7 & 8 (Latest 2022/ 2023): Advanced Pharmacology Fundamentals - Chamberlain College Of Nursing.

NR566 Final Exam Study Guide Week 5 - Prevention of osteoporosis with hormone replacement therapy Tara (p.433) Hormone therapy reduces postmenopausal bone loss and thereby decreases the risk for osteoporosis and related fractures. Therapy is lifelong and the risk for harm is increased. Hormone therapy should only be considered for women with significant risk for osteoporosis, and only when that risk outweighs the risks of hormone therapy. Meds are: raloxifene (Evista), bisphosphonates (e....

Week 5 • Prevention of osteoporosis with hormone replacement therapy o Selective Estrogen Receptor Modulators (SERMs) ▪ Tamoxifen (Nolvadex-D), Toremifene (Fareston), Raloxifene (Evista), and Bazedoxifene (Duavee - postmenopausal women drug) ▪ These drugs provide benefits of estrogen (protection against osteoporosis, maintenance of the urogenital tract, reduction of LDL cholesterol) while avoiding its drawbacks (promotion of breast cancer, uterine cancer, and thromboembolism) o Prev...

Prevention of osteoporosis with hormone replacement therapy Tara (p.433) Hormone therapy reduces postmenopausal bone loss and thereby decreases the risk for osteoporosis and related fractures. Therapy is lifelong and the risk for harm is increased. Hormone therapy should only be considered for women with significant risk for osteoporosis, and only when that risk outweighs the risks of hormone therapy. Meds are: raloxifene (Evista), bisphosphonates (e.g., alendronate {Fosamax}), calcitonin (...

NR 565 Final Review - A Comprehensive Review of Week 5-8 Content for NR 565 Final. NR565 Week 5 Chapter 24: Drugs used in treating infectious diseases (p. 692-760)Antimicrobial resistance • Causes of drug resistance o Recent use of antibiotics o Overuse of broad-spectrum antibiotics o Age younger than 2 years or older than 65 years o Daycare center attendance o Exposure to young children o Multiple medical comorbidities o Immunosuppression • Every antibiotic class has resistance o...